JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Piper Sandler
PIPR
$5.54B
| $1.9M | ﹤0.01% |
95,228
-72,364
| -43% | -$1.4M |
|
3277
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20.3B
| $1.9M | ﹤0.01% |
11,951
+4,865
| +69% | +$742K |
|
3278
Matsons
MATX
$6.39B
| $1.89M | ﹤0.01% |
46,353
-7,292
| -14% | -$278K |
|
|
LGF.B
3279
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $1.89M | ﹤0.01% |
190,552
-75,866
| -28% | -$655K |
|
3280
VEON
VEON
$3.93B
| $1.89M | ﹤0.01% |
29,797
-38,987
| -57% | -$2.4M |
|
3281
Spok Holdings
SPOK
$230M
| $1.88M | ﹤0.01% |
153,575
-17,710
| -10% | -$209K |
|
3282
PUT
AstraZeneca
AZN
$244B
| $1.87M | ﹤0.01% |
+18,750
| New | +$1.77M |
|
3283
Seres Therapeutics
MCRB
$45M
| $1.87M | ﹤0.01% |
27,094
-2,498
| -8% | -$185K |
|
3284
State Street SPDR MSCI USA Gender Diversity ETF
SHE
$339M
| $1.86M | ﹤0.01% |
24,094
-2,218
| -8% | -$167K |
|
3285
State Street SPDR S&P Regional Banking ETF
KRE
$4.67B
| $1.86M | ﹤0.01% |
31,932
-5,162,760
| -99% | -$286M |
|
3286
PUT
Nokia
NOK
$59B
| $1.85M | ﹤0.01% |
500,000
| – | – |
|
3287
Aquestive Therapeutics
AQST
$533M
| $1.85M | ﹤0.01% |
318,581
+206,778
| +185% | +$1.08M |
|
|
HALL
3288
DELISTED
Hallmark Financial Services, Inc.
HALL
| $1.85M | ﹤0.01% |
10,548
-1,595
| -13% | -$292K |
|
3289
Sabesp
SBS
$16.5B
| $1.85M | ﹤0.01% |
633,706
-1,786,889
| -74% | -$4.59M |
|
|
WSR
3290
DELISTED
Whitestone REIT
WSR
| $1.85M | ﹤0.01% |
135,672
-33,898
| -20% | -$465K |
|
|
UCFC
3291
DELISTED
United Community Financial Corp
UCFC
| $1.85M | ﹤0.01% |
158,390
-99,421
| -39% | -$1.11M |
|
3292
Intellia Therapeutics
NTLA
$1.66B
| $1.85M | ﹤0.01% |
125,815
+113,140
| +893% | +$1.57M |
|
3293
Zurn Elkay Water Solutions
ZWS
$8.41B
| $1.84M | ﹤0.01% |
117,412
+7,843
| +7% | +$113K |
|
3294
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
| $1.84M | ﹤0.01% |
21,808
-2,528
| -10% | -$200K |
|
3295
CALL
Prologis
PLD
$134B
| $1.84M | ﹤0.01% |
20,600
-18,000
| -47% | -$1.6M |
|
|
3296
PUT
Prologis
PLD
$134B
| $1.84M | ﹤0.01% |
20,600
-38,000
| -65% | -$3.37M |
|
3297
CALL
Stryker
SYK
$131B
| $1.83M | ﹤0.01% |
8,700
-20,800
| -71% | -$4.32M |
|
3298
CALL
Skyworks Solutions
SWKS
$10.5B
| $1.82M | ﹤0.01% |
15,100
| – | – |
|
|
3299
PUT
Skyworks Solutions
SWKS
$10.5B
| $1.82M | ﹤0.01% |
15,100
| – | – |
|
3300
Allient
ALNT
$1.86B
| $1.82M | ﹤0.01% |
56,399
+10,655
| +23% | +$297K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.